20
Participants
Start Date
May 31, 2008
Primary Completion Date
August 31, 2009
Study Completion Date
August 31, 2009
glucarpidase, high-dose methotrexate, leucovorin
single intravenous dose
high-dose methotrexate, leucovorin
standard of care, leucovorin every 6 hours
Children's Hospital of Philadelphia, Philadelphia
ECU Brody School of Medicine, Greenville
St. Joseph's Hospital, Tampa
St. Jude Children's Research Hospital, Memphis
University of MS Medical Center, Jackson
University of Kentucky, Lexington
Gabrail Cancer Center, Canton
Riley Hospital for Children, Indianapolis
NorthShore University Health System, Evanston
Washington University Medical Center, St Louis
University of Missouri-Columbia, Columbia
St. Elizabeth Regional Medical Center, Lincoln
Texas Children's Hospital, Houston
Children's Hospital for Cancer & Blood Disorders, Aurora
Huntsman Cancer Center, Salt Lake City
Phoenix Children's Hospital, Phoenix
Good Samaritan Hospital, Los Angeles
Children's Hospital of Los Angeles, Los Angeles
Children's Hospital of Orange County, Los Angeles
California Pacific Medical Center, San Francisco
Oakland's Children's Hospital, Oakland
Children's Hospital and Regional Medical Center, Seattle
Stanford University Medical Center & Lucile Packard Children's Hospital, Palo Alto
University of Massachusetts - Umass Memorial Medical Center, Worcester
Hackensack University Medical Center, Hackensack
Lead Sponsor
BTG International Inc.
OTHER